Therapeutic drug monitoring to optimize vancomycin level for pediatric patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20180818003

Enrollment

Registered

2018-08-18

Start date

2018-06-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vancomycin concentration in blood vancomycin concentration MRSA AUC

Interventions

Other

Eligibility

Sex/Gender

All

Age

1 Months to 18 Years

Inclusion criteria

Inclusion criteria: age > 1 month and < 18 years receiving vancomycin when being admitted in KCMH consent to participate in the project

Exclusion criteria

Exclusion criteria: renal failure or abnormal serum Cr, depends on age receiving renal replacement therapy or ECMO receiving amphotericin B, cyclosporin, tacrolimus

Design outcomes

Primary

Measure	Time frame
agreement of AUC calculation methods one year Bland Altman analysis	—

Secondary

Measure	Time frame
correlation of AUC and trough concentration one year Pearson correlation and linear regression	—

Countries

Thailand

Contacts

Public ContactSuvaporn Anugulruengkitt

Faculty of Medicine, Chulalongkorn University

anugul.sa@gmail.com+66894818922

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026